Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.32 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29604207 | 1.00 | CDK5 (0.32) | CDK5CDK5R1NR1I3 | |
| SCHEMBL333147 | 1.00 | CDK5 (0.32) | CDK5CDK5R1NR1I3 | |
| SCHEMBL6543134 | 0.81 | GRIN1 (0.34) | NR1I3 | |
| SCHEMBL3890866 | 0.80 | AKR1B10 (0.33) | NR1I3 | |
| SCHEMBL29637260 | 0.75 | — | — | |
| SCHEMBL16774422 | 0.75 | — | — | |
| SCHEMBL11672814 | 0.74 | NR1I3 (0.50) | CDK5CDK5R1NR1I3 | |
| SCHEMBL11671836 | 0.74 | NR1I3 (0.50) | CDK5CDK5R1NR1I3 | |
| SCHEMBL11671840 | 0.74 | NR1I3 (0.50) | CDK5CDK5R1NR1I3 | |
| SCHEMBL11673103 | 0.74 | NR1I3 (0.50) | CDK5CDK5R1NR1I3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 941 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118745189-B | Guaiane-eudesman sesquiterpene dimer and preparation method and application thereof | 中国科学院昆明植物研究所 | 2025-05-16 | — | — | CN | claimed |
| CN-118745189-A | Guaiane-eudesman sesquiterpene dimer and preparation method and application thereof | 中国科学院昆明植物研究所 | 2024-10-08 | — | — | CN | claimed |
| US-20240324588-A1 | ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS | Genesee Valley Innovations, LLC | 2024-10-03 | — | — | US | claimed |
| CN-118717754-A | Lipid lowering application of 3 beta-angeloyloxy-4 alpha, 8 beta-dihydroxyl-eudesman-7 (11) -alkene-12, 8 alpha-lactone | 大理大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118717747-A | Dodelate C lipid lowering application | 大理大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118702658-A | Dobinin C and preparation and lipid-lowering application of acylated derivative thereof | 大理大学 | 2024-09-27 | — | — | CN | claimed |
| CN-118652230-A | Eucalyptus type sesquiterpene dimer compound and preparation method and application thereof | 西南大学 | 2024-09-17 | — | — | CN | claimed |
| CN-118324734-A | A series of eudesmane sesquiterpenoids in herba Artemisiae Annuae, and its preparation method and application | 中国科学院新疆理化技术研究所 | 2024-07-12 | — | — | CN | claimed |
| CN-115583981-B | Eucalyptus alkane type sesquiterpene glycoside compound, erythrina ovalifolia extract containing compound and application of compound | 西北农林科技大学 | 2024-04-12 | — | — | CN | claimed |
| CN-116947794-B | Eucalyptus type sesquiterpenoids rearranged by four-ring system, preparation method and application thereof, pharmaceutical composition and application thereof | 云南中医药大学 | 2023-11-28 | — | — | CN | claimed |
| WO-2008027515-A2 | PHOSPHORUS-CONTAINING STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027511-A1 | EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| EP-1885728-A1 | CONVERSION OF AMORPHA-4,11- DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS | Amyris Biotechnologies, Inc. (US) | 2008-02-13 | — | — | EP | claimed |
| WO-2007126760-A2 | COMPOSITIONS COMPRISING IODOTRIFLUOROMETHANE AND STABILIZERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-08 | — | — | WO | claimed |
| CN-101050209-A | Eudesmane type sesquiterpene lactone compound extracted from Carpesium macrocephalum and having antibacterial activity, and its application | CT OF NON HARM PESTICIDE RES & (CN) | 2007-10-10 | — | — | CN | claimed |
| CN-1951378-A | Medical usage of 2beta-hydroxyilicicacid in inhibiting hepatitis B | WENZHOU MEDICAL COLLEGE (CN) | 2007-04-25 | — | — | CN | claimed |
| CN-1927197-A | Medical use of 1beta-keto-5, 11(13)-diene eudesmane-12-acid for inhibiting hepatitis B virus | WENZHOU MEDICAL COLLEGE (CN) | 2007-03-14 | — | — | CN | claimed |
| CN-1923787-A | Eudesmane type sesquiterpenes acid and application thereof | UNIV ZHEJIANG (CN) | 2007-03-07 | — | — | CN | claimed |
| WO-2006128126-A1 | CONVERSION OF AMORPHA-4,11- DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2006-11-30 | — | — | WO | claimed |
| US-20060270863-A1 | CONVERSION OF AMORPHA-4,11-DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS | AMYRIS BIOTECHNOLOGIES (US) | 2006-11-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060270863-A1 | CONVERSION OF AMORPHA-4,11-DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS | SQLE, CYP4A11, DHPS | CDK5 2063/4885CDK5R1 1221/4885NR1I3 920/4885 |
| US-20240324588-A1 | ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS | EXOSC9, EXOSC4, PHOSPHO1 | CDK5 2484/4885CDK5R1 2432/4885NR1I3 2091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.